Willingness To Pay To Eliminate the Risk of Restenosis Following Percutaneous Coronary Intervention A Contingent Valuation

被引:2
|
作者
Guertin, Jason R. [1 ,2 ]
Liu, Aihua [3 ,4 ]
Abrahamowicz, Michal [3 ,4 ]
Cohen, David J. [6 ]
Ismail, Salma [2 ]
LeLorier, Jacques [1 ,2 ]
Brophy, James M. [3 ,4 ,5 ]
Rinfret, Stephane [2 ,7 ]
机构
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[2] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2011年 / 4卷 / 01期
关键词
restenosis; stents; cost-benefit analysis; SIROLIMUS-ELUTING STENTS; HIERARCHICAL BAYESIAN METAANALYSIS; HEALTH-CARE; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; ANGIOPLASTY; TRIALS;
D O I
10.1161/CIRCOUTCOMES.109.915421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Percutaneous coronary intervention (PCI) remains limited by the risk of restenosis. Patients' perceptions of the health benefits and value of avoiding restenosis are incompletely known. Methods and Results-We used a contingent valuation approach to assess the willingness to pay (WTP) for a hypothetical treatment that eliminates the risk of restenosis among 270 PCI patients. Patients were provided with a scenario describing a baseline 10% or 20% probability of restenosis in the year following the procedure, which could lead to repeat PCI or, more rarely, bypass surgery, without any increase in mortality. Six different "take it or leave it" bids ($500, $1000, $1500, $2000, $2500, and $3000) and both risk levels were randomly assigned. Multiple logistic regression was used to identify independent predictors of a positive response to the WTP question. Using nonparametric methods, the median WTP to eliminate the risk of restenosis was estimated at $2802. As expected, higher income was independently associated with a higher probability of a positive response to the WTP question (odds ratio, 2.81; 95% CI, 1.32 to 5.97). Bids also were independently associated with the probability of being willing to pay, and this association followed a quadratic effect. Below $1500, bid had little impact on patient answers. However, as prices increased, the probability of being willing to pay started to decrease sharply. Conclusion-The potential to eliminate the risk of restenosis, a benign complication, would have substantial value for patients undergoing PCI. (Circ Cardiovasc Qual Outcomes. 2011;4:46-52.)
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [1] Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study
    Greenberg, D
    Bakhai, A
    Neumann, PJ
    Cohen, DJ
    HEALTH POLICY, 2004, 70 (02) : 207 - 216
  • [2] Antisense therapy for restenosis following percutaneous coronary intervention
    Kipshidze, N
    Tsapenko, M
    Iversen, P
    Burger, D
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (01) : 79 - 89
  • [3] Differences between willingness to pay and willingness to accept for visits by a family physician: A contingent valuation study
    Martin-Fernandez, Jesus
    Isabel del Cura-Gonzalez, Ma
    Gomez-Gascon, Tomas
    Oliva-Moreno, Juan
    Dominguez-Bidagor, Julia
    Beamud-Lagos, Milagros
    Javier Perez-Rivas, Francisco
    BMC PUBLIC HEALTH, 2010, 10
  • [4] Endothelial dysfunction and restenosis following percutaneous coronary intervention
    Thanyasiri, Panuratn
    Kathir, Krishna
    Celermajer, David S.
    Adams, Mark R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 119 (03) : 362 - 367
  • [5] Willingness to Pay for Diagnostic Technologies: A Review of the Contingent Valuation Literature
    Lin, Pei-Jung
    Cangelosi, Michael J.
    Lee, David W.
    Neumann, Peter J.
    VALUE IN HEALTH, 2013, 16 (05) : 797 - 805
  • [6] Willingness to pay for reducing fatal risk by improving air quality: A contingent valuation study in Chongqing, China
    Wang, Hong
    Mullahy, John
    SCIENCE OF THE TOTAL ENVIRONMENT, 2006, 367 (01) : 50 - 57
  • [7] Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
    Zholdybayeva, Elena V.
    Talzhanov, Yerkebulan A.
    Aitkulova, Akbota M.
    Tarlykov, Pavel V.
    Kulmambetova, Gulmira N.
    Iskakova, Aisha N.
    Dzholdasbekova, Aliya U.
    Visternichan, Olga A.
    Taizhanova, Dana Zh
    Ramanculov, Yerlan M.
    HUMAN GENOMICS, 2016, 10
  • [8] Genetic risk factors and restenosis after percutaneous coronary interventions
    Kastrati, A
    Dirschinger, J
    Schömig, A
    HERZ, 2000, 25 (01) : 34 - 46
  • [9] Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention
    Monraats, Pascalle S.
    de Vries, Florentine
    de Jong, Laura W.
    Pons, Douwe
    Sewgobind, Varsha D. K. D.
    Zwinderman, Aeilko H.
    De Maat, Moniek P. M.
    't Hart, Leen M.
    Doevendans, Pieter A.
    de Winter, Robbert J.
    Tio, Rene A.
    Waltenberger, Johannes
    Frants, Rune R.
    van der Laarse, Arnoud
    Van der Wall, Ernst E.
    Jukema, J. Wouter
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (10) : 747 - 754
  • [10] Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention
    Hodish, I
    Matetzky, S
    Selah, BA
    Guetta, V
    Goldenberg, I
    Doolman, R
    Freimark, D
    Hod, H
    CARDIOLOGY, 2002, 97 (04) : 214 - 217